For: |
Lee JC, Bell DC, Guinness RM, Ahmad T. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i15/1897.htm |
Number | Citing Articles |
1 |
Clairton Marcolongo-Pereira, Adriana Stigger, Letícia Fiss, Ana Carolina Coelho, Bianca Santos, Sergio Vargas Junior, Ana Lucia Schild. Pneumomediastinum and subcutaneous emphysema in a rabid bull. Ciência Rural 2015; 45(1): 68 doi: 10.1590/0103-8478cr20140672
|
2 |
Babar Ahmad Khan, Sania Khan, Benjamin White, Ambika Eranki. Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature. Respiratory Medicine Case Reports 2017; 22: 179 doi: 10.1016/j.rmcr.2017.08.012
|
3 |
Alistair B. Reid, Sharon C.-A. Chen, Leon J. Worth. Pneumocystis jirovecii pneumonia in non-HIV-infected patients. Current Opinion in Infectious Diseases 2011; 24(6): 534 doi: 10.1097/QCO.0b013e32834cac17
|
4 |
Anna Cancelliere, Giada Procopio, Maria Mazzitelli, Elena Lio, Maria Petullà, Francesca Serapide, Maria Chiara Pelle, Chiara Davoli, Enrico Maria Trecarichi, Carlo Torti. A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal cannula and review of the literature: Is this a “spontaneous” complication?. Clinical Case Reports 2021; 9(5) doi: 10.1002/ccr3.4007
|
5 |
Saquib Navid Siddiqui, Umair Falak, Ned Frost, Mohamed Awad. An intriguing tale of pneumomediastinum and subcutaneous emphysema in staphylococcal pneumonia: a rare case and literature review of subcutaneous drain insertion. Breathe 2024; 20(1): 230154 doi: 10.1183/20734735.0154-2023
|
6 |
|
7 |
Maneesh Dave, Treta Purohit, Raymund Razonable, Edward V. Loftus. Opportunistic Infections Due to Inflammatory Bowel Disease Therapy. Inflammatory Bowel Diseases 2014; 20(1): 196 doi: 10.1097/MIB.0b013e3182a827d2
|
8 |
Hazim S. Bukamur, Emhemmid Karem, Serag Fares, Mohammed Al-Ourani, Amro Al-Astal. Pneumocystis Jirovecii (carinii) pneumonia causing lung cystic lesions and pneumomediastinum in non-HIV infected patient. Respiratory Medicine Case Reports 2018; 25: 174 doi: 10.1016/j.rmcr.2018.08.025
|
9 |
Atsushi Yoshida, Noriko Kamata, Akihiro Yamada, Yoko Yokoyama, Teppei Omori, Toshimitsu Fujii, Ryohei Hayashi, Tetsu Kinjo, Akira Matsui, Norimasa Fukata, Sakuma Takahashi, Ryosuke Sakemi, Noriyuki Ogata, Shinya Ashizuka, Shigeki Bamba, Makoto Ooi, Shuji Kanmura, Katsuya Endo, Takuya Yoshino, Hiroki Tanaka, Toshio Morizane, Shinichiro Shinzaki, Taku Kobayashi. Risk Factors for Mortality in <b><i>Pneumocystis jirovecii</i></b> Pneumonia in Patients with Inflammatory Bowel Disease. Inflammatory Intestinal Diseases 2018; 3(4): 167 doi: 10.1159/000495035
|
10 |
Malcolm A. Finkelman. Pneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility. Critical Reviews in Microbiology 2010; 36(4): 271 doi: 10.3109/1040841X.2010.484001
|
11 |
Filip Y. De Vos, Johanna M. Gijtenbeek, Chantal P. Bleeker-Rovers, Carla M. van Herpen. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. Critical Reviews in Oncology/Hematology 2013; 85(3): 373 doi: 10.1016/j.critrevonc.2012.08.002
|
12 |
Sally J. Lawrence, Manish Sadarangani, Kevan Jacobson. Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review. Frontiers in Pediatrics 2017; 5 doi: 10.3389/fped.2017.00161
|
13 |
Thomas G. Cotter, Nicola Gathaiya, Jelena Catania, Edward V. Loftus, William J. Tremaine, Larry M. Baddour, W. Scott Harmsen, Alan R. Zinsmeister, William J. Sandborn, Andrew H. Limper, Darrell S. Pardi. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression. Clinical Gastroenterology and Hepatology 2017; 15(6): 850 doi: 10.1016/j.cgh.2016.11.037
|
14 |
Yusuke Watanabe, Kazunao Hayashi, Shuji Terai. A Rare Case of Ulcerative Colitis with Severe <i>Pneumocystis jirovecii</i> Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review. Internal Medicine 2022; 61(3): 339 doi: 10.2169/internalmedicine.7953-21
|
15 |
Caroline M. Sierra, Krishna C. Daiya. Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2022; 42(11): 858 doi: 10.1002/phar.2733
|
16 |
Noor H Bouwmeester, Hans Kieft, Ghada MM Shahin, Arno P Nierich. A novel approach to resolve severe mediastinal and subcutaneous emphysema occurring in Pneumocystis jirovecii pneumonia using vacuum-assisted closure therapy. SAGE Open Medical Case Reports 2020; 8 doi: 10.1177/2050313X20918989
|